Navigation Links
Rapid Generic Erosion of Branded Agents, Including Market-Leading Viagra, Will Cause Sales of Erectile Dysfunction Drugs to Remain Flat Over the Next Decade
Date:1/19/2009

However, Increases in the Drug Treated Population Will Temper Losses Incurred by Leading Agents, According to a New Report from Decision Resources

WALTHAM, Mass., Jan. 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the anticipated launch of five emerging drugs during the 2007-2017 forecast period, total sales for erectile dysfunction therapies will remain relatively constant, totaling $2.2 billion in 2007 and $2.1 billion in 2017. Rapid generic erosion, following patent expiries that begin in the United States in 2012 for the market leader, Pfizer's Viagra (sildenafil), will be the key event impacting the erectile dysfunction market. However, the decline in Viagra sales will be tempered by more widespread use of sildenafil overall, as greater numbers of patients are expected to seek treatment and receive prescription drug therapy for erectile dysfunction when less-expensive, generic versions of sildenafil become available.

The new Pharmacor report entitled Erectile Dysfunction finds that while therapeutic substitution of less-expensive, generic sildenafil for branded phosphodiesterase type 5 (PDE5) inhibitors will contribute to a significant loss of sales for Eli Lilly's Cialis and Bayer Healthcare/Schering-Plough/GlaxoSmithKline's Levitra, the availability of generic PDE5 inhibitors will encourage more patients to seek treatment for erectile dysfunction, driving increases in the diagnosed and drug-treated populations through 2017 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

According to the report, opportunity remains for emerging agents that can treat patients who do not respond to treatment with available PDE5 inhibitors or for whom these agents are contraindicated. However
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Allergy Sufferers to Benefit from New, Improved Rapid Relief Medication This Spring
2. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
3. Belmont(R) Rapid Infuser Helps Save Officers Life
4. Rapid Response Teams Dont Cut Hospital Heart Attacks, Death Rates
5. Ultrasound waves aid in rapid treatment of DVT
6. Frutarom Continues to Implement its Rapid Growth Strategy
7. New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections
8. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
9. Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer
10. Cancer Patients in Southeastern Florida Now Benefiting From RapidArc(TM) Radiotherapy Treatments
11. Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...NEW ORLEANS, Nov. 30 SE... the global corporation Sodexo will hold a rally T... and Maintenance headquarters, 3800 Desire Parkway...licy and arbitrary disciplinary policies that targ...n ill family member. Sodexo employees who clean sc...
(Date:11/30/2009)...HARLTON, Mass., Nov. 30 Harrington...he addition of Family Practice physicians Martin D...hur to its Charlton practice. ,, These four e...ing from the Fallon Clinic, will soon join the Har... Charlton medical office building under constructi...
(Date:11/30/2009)... tiny period of time between the registration of a...onscious recognition of it ― between the tim...an apple. Our minds lag behind our eyes, but by ho...the world around us? , Some estimates say the ... 500 milliseconds. A new study by Tel Aviv Univers...
(Date:11/30/2009)...cial skills improve with specially designed progra...thDay News) -- A special, intensive early interven... boosting IQ along with children,s language and so... this fashion, many children are able to learn and... lead author of the study, published online Nov. 3...
(Date:11/30/2009)... , SILVER SPRING, Md., Nov. 30 /PRNewswire-USN...umers a bronzed body year-round, but the ultraviol... health risks. ,, (Logo: http://www.newscom.c...h some people think that a tan gives them a ,healt...Sharon Miller, M.S.E.E., a Food and Drug Administr...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4
... health conditions are potentially around the corn...tudy. The findings, which were based on analys...cells, appear online March 6 in the American Journ... M.D., Ph.D., professor of psychiatry in the UI Ro...
...ty goers at night clubs has prompted authorities t...ners to refrain from such acts, lest they risk fac... Medicines and Healthcare Products Regulatory Agen...uncils have been asked to warn the clubs, festival...
... a method that could lead to a single vaccine agai...e dengue virus causes dengue hemorrhagic fever, sh...all sufficiently different that individuals vaccin... against all types of dengue virus. But John...
...ts of a study showing clearly that soft drinks are...r body weight, a decrease in calcium and other nut... The report also noted that studies funded by t...analyzed 88 previously published studies obtained ...
...ain reliever for children suffering severe musculo...and codeine. Details of the study are published in... Nearly 336 children aged from 6 to 17 sought tre...he children were randomly administered oral doses ...
...rt treatment for morbidly obese adults with accomp...rformed in teens. As statistics from research... New Jersey show, the use of surgery to treat obes...a year in which 771 of these operations were perfo...
Other Medicine News:Health News:Blood Tests may Be Possible for Mental Health Conditions 2Health News:Yale Researchers Weigh the Science on Soft Drinks and Health 2Health News:Extreme Treatment for Obese Teens Becoming a Fad 2
(Date:11/30/2009).../ -- Reportlinker.com announces that a new market ..., Inflammatory Disorders: Therapies That Suppres...w.reportlinker.com/p0165600/Inflammatory-Disorders...ponse.html ,, The human immune system can go a...ing an exaggerated response to a foreign substance...
(Date:11/30/2009)... Jocelyn Rapelyea, Associate Director of Breast Im...sity Medical Center in Washington, D.C., demonstra...ific Gamma Imaging (BSGI) can be localized utilizi...l, as for pre-operative localization today at the ...h America (RSNA). ,, BSGI was conducted using a...
(Date:11/30/2009)...- Minimally-invasive procedures are increasingly r... oncology, cardiology and women,s health applicati...tion expected to reach $600 million by 2015, clini...mally-invasive procedures, including shorter patie...ter patient throughput. ,, (Logo: http://www...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Lexington Health Care Names New Chief Executive Officer 51899 1Lexington Health Care Names New Chief Executive Officer 51899 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 1Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 3Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 4PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 1PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 2
...ults of Roche and Ipsen,s First Once-Weekly Human ...iation Meeting -, NUTLEY, N.J., June 10 Roche an...poglutide (R1583) has been shown to provide,signif...oss after only,eight weeks of treatment(1,2) with ...try into Phase III. Taspoglutide, originating from...
...estigational Diabetes Therapy Also Improved Glucos... Taken Twice a Day, SAN FRANCISCO, June 9 Amylin...and Company (NYSE: LLY ), and Alkermes, Inc.,(Nas...k open-label clinical,study that showed the durabl... release formulation of exenatide. Patients taking...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9
Laser Contact Lens Retina 145 L
Laser 3 mirror Contact Lens 907 L
Laser 3 mirror Contact Lens 630 L
...mplete image capture and management application th...l leading ophthalmic clinicians, ophthalmic photog...urately and securely document the eye via the slit...slit lamps equipped with digital or video cameras ...
Medicine Products: